Lv1
50 积分 2023-01-29 加入
甲状腺癌分子分型驱动精准诊疗的转化与挑战
6个月前
已完结
Daratumumab-bortezomib-thalidomide-dexamethasone for newly diagnosed myeloma: CASSIOPEIA minimal residual disease results
7个月前
已完结
INDICATIONS AND CONTRAINDICATIONS FOR TREATMENT OF THYROID CANCER WITH RADIOACTIVE IODINE
8个月前
已完结
[Expert consensus on the diagnosis and treatment of advanced non-small cell lung cancer with EGFR PACC mutations (2025 edition)]
10个月前
已完结
[Expert consensus on diagnosis and treatment of advanced non-small cell lung cancer with HER-2 alterations (2025 edition)]
10个月前
已完结
Combination kinase inhibitors and immunotherapy for unresectable anaplastic thyroid carcinoma: A retrospective single-center study
1年前
已完结
皖公网安备34019202002308
